Optic atrophy 1 (OPA1) mutations cause dominant optic atrophy (DOA) with retinal ganglion cell (RGC) and optic nerve degeneration. The mechanism for the selective degeneration of RGCs in DOA remains elusive. To address the mechanism, we reduced OPA1 protein expression in cell lines and RGCs by RNA interference. OPA1 loss results in mitochondrial fragmentation, deficiency in oxidative phosphorylation, decreased ATP levels, decreased mitochondrial Ca 2 þ retention capacity, reduced mtDNA copy numbers, and sensitization to apoptotic insults. We demonstrate profound cristae depletion and loss of crista junctions in OPA1 knockdown cells, whereas the remaining crista junctions preserve their normal size. OPA1-depleted cells exhibit decreased agonist-evoked mitochondrial Ca 2 þ transients and corresponding reduction of NAD þ to NADH, but the impairment in NADH oxidation leads to an overall more reduced mitochondrial NADH pool. Although in our model OPA1 loss in RGCs has no apparent impact on mitochondrial morphology, it decreases buffering of cytosolic Ca 2 þ and sensitizes RGCs to excitotoxic injury. Exposure to glutamate triggers delayed calcium deregulation (DCD), often in a reversible manner, indicating partial resistance of RGCs to this injury. However, when OPA1 is depleted, DCD becomes irreversible. Thus, our data show that whereas OPA1 is required for mitochondrial fusion, maintenance of crista morphology and oxidative phosphorylation, loss of OPA1 also results in defective Ca 2 þ homeostasis.
Mutations in optic atrophy 1 (OPA1), a dynamin-related large GTPase with mitochondrial fusion function, cause dominant optic atrophy (DOA), the most common hereditary form of optic neuropathy. 1, 2 Progressive degeneration of retinal ganglion cells (RGCs) and the optic nerve, the hallmarks of DOA, are associated with several functional and structural alterations of mitochondria (reviewed in Lenaers et al. 3 ). Whereas the OPA1 mutation in DOA patients is present from birth in all cells, it remains unknown why only certain cell types, such as RGCs, degenerate [4] [5] [6] [7] [8] and what are the mechanisms leading to their loss.
In addition to its role in mitochondrial fusion, OPA1 governs crista architecture. OPA1 is anchored in the mitochondrial inner membrane and faces the intermembrane space. 9, 10 Electron microscopy (EM) analyses indicate that OPA1 loss causes abnormal mitochondrial ultrastructure with cristae disorganization. [9] [10] [11] Interaction of OPA1 with membranes can induce a structural remodeling into tubules, 12 a feature characteristic of crista junctions, [13] [14] [15] supporting the proposal that OPA1 is a key component of these junctions. [16] [17] [18] Because crista junctions are normally uniform, a change in their size may indicate alteration in mitochondrial functional status. Yet, disagreements have arisen concerning crista junction remodeling in apoptosis. [17] [18] [19] [20] [21] Emerging evidence suggests that abnormal Ca 2 þ homeostasis contributes to the pathogenesis in DOA. 22, 23 Ca 2 þ enters mitochondria via the Ca 2 þ uniporter where it stimulates NADH and ATP production via activation of NADHproducing dehydrogenases including pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, and NAD-linked isocitrate dehydrogenase. 24 During neurotransmission, ionotropic glutamate receptors, including the N-methyl-D-aspartate (NMDA) receptor, open and cytoplasmic Ca 2 þ accumulates in neurons and regulates downstream enzymes and signaling pathways. 25 However, if excessive glutamate is released into the extracellular space, for example, during stroke, epilepsy, or neuronal injury, neurons suffer excitotoxic damage. In cell culture models, a phenomenon known as delayed Ca deregulation (DCD) occurs during acute glutamate exposure. 26, 27 DCD is thought to be a consequence of mitochondrial Ca 2 þ overload-mediated injury, 28 and in most paradigms leads to neuronal cell death. 29, 30 Remarkably, RGCs are known to be resistant to excitotoxicity in contrast to hippocampal neurons. 31 To investigate the mechanism of RGC degeneration in DOA, OPA1 expression in cell lines and primary RGCs was decreased by RNAi, and ultrastructure, bioenergetics, and Ca 2 þ homeostasis of control and RNAi cells were compared. We demonstrate that in RGCs, decreased mitochondrial Ca 2 þ buffering and DCD occur in the absence of significant changes in mitochondrial morphology, suggesting a functional role of OPA1 in Ca 2 þ signaling.
Results
OPA1 loss results in mitochondrial fission and sensitization to apoptosis. To explore the effects of OPA1 loss on cellular function we transfected cells with OPA1 small interfering RNA (siRNA). Because RGCs constitute only 1% of all cells in the retina and the yields are low after purification, we were forced to use cell lines (HeLa cells) for some experiments. Although control HeLa cells exhibited a typical fused mitochondrial network, B80% of OPA1 siRNA cells showed dramatic mitochondrial fragmentation ( Figure 1a ). Effective OPA1 knockdown was confirmed by immunoblotting (Supplementary Figure 1) . Previous studies have reported that cells lacking OPA1 spontaneously release cytochrome c from mitochondria and undergo cell death. 9, 32 However, subcellular fractionation with immunoblotting ( Figure 1b ) and confocal microscopy of OPA1 siRNA cells (Figures 1c and d ) demonstrated that OPA1 knockdown did not result in spontaneous cytochrome c release from mitochondria. Measurements of cell death by three independent methods (Figures 1e-g and Supplementary Figure 2 ) did not reveal greater than baseline cell death in OPA1 siRNA cells. However, in agreement with an earlier study, 32 OPA1 siRNA cells died faster when challenged with staurosporine (STS), an apoptosis inducer, and exhibited a significantly higher caspase activity after STS treatment than STS-treated control cells (Figures 1e and f) . Taken together, these data indicate that OPA1 loss per se does not cause cytochrome c release from mitochondria or cell death; instead, it conveys an increased susceptibility to apoptosis.
OPA1 loss leads to cristae depletion. Conventional 2D EM analyses demonstrate that OPA1 loss causes abnormal mitochondrial ultrastructure. [9] [10] [11] However, a detailed 3D picture and quantitative analysis of the mitochondrial ultrastructure in intact, mammalian OPA1-deficient cells are lacking. Only 3D reconstructions of isolated mitochondria from OPA1-null cells were published previously. 17 To gain better insights into the mitochondrial ultrastructure in OPA1 knockdown cells, we performed EM tomography and a highresolution mitochondrial quantitative analysis. Additionally, in tomographic volumes, we quantified mitochondrial numbers per cubic micron and mitochondrial volume relative to cellular volume. Although there was no difference in the total mitochondrial volume, mitochondrial number increased twofold in OPA1 siRNA-transfected cells (Figures 2Ca and b) . These results confirm that OPA1 loss promotes mitochondrial fission rather than a decrease in mitochondrial density. We also measured cristae surface area compared with that of the OMM surface area and evaluated cristae surface area relative to cell volume (Figures 2Cc and  d) . The total cristae membrane surface area of OPA1 siRNAtransfected cells was 25% less than that of controls (Figures 2Cc and d) .
OPA1 loss leads to mitochondrial structural heterogeneity, but not widening of crista junctions. Because of the report of heterogeneity in mitochondrial membrane potential (Dc m ) after OPA1 loss, 33 we investigated possible accompanying structural heterogeneity. Using conventional EM, we found that B10% of mitochondria were considerably more condensed than the majority (Figures 3a-e) . To clarify whether crista junction changes occurred in our OPA1 siRNA samples, we measured junctional sizes in tomographic volumes. In agreement with the previous report, 17 we found that the junctional size remains essentially unaltered with loss of OPA1 (Figures 3f-h; 10.0 ± 0.4 nm for control and 8.9 ± 0.5 nm for OPA1 siRNA crista junctions; mean ±S.E.M.). However, the number of junctions was significantly reduced in OPA1 siRNA mitochondria (Figure 3h ; 54 ± 4 CJ/S.A. for control and 21 ± 6 CJ/S.A. for OPA1 siRNA; mean±S.E.M.; Po.001). Loss of crista junctions is consistent with cristae depletion ( Figure 2) ; this phenomenon was also reported in a previous study using a TOM19-removal mechanism for cristae depletion. 34 Collectively our findings indicate that OPA1 loss results in cristae depletion without dilation of their junctions.
OPA1 loss results in bioenergetic defects, mtDNA loss, and impaired mitochondrial Ca 2 þ buffering. Because mitochondrial cristae are abnormal in OPA1 siRNA cells, we investigated the impact of these abnormalities on bioenergetics. Respiratory changes induced by OPA1 knockdown were evaluated in digitonin-permeabilized and intact cells. To measure respiration in digitonin-permeabilized cells, mitochondria were supplemented with Complex I-linked substrates, glutamate and malate. The rates of ADP-induced (state 3) and maximal (carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP)-induced or state 3u) respiration were reduced by B20% in OPA1 siRNA cells compared with controls ( Figure 4A and Table 1 ). Comparable inhibition of respiration was observed in intact OPA1 siRNA cells ( Table 1 ). Note that the oligomycin-inhibited (state 4o) respiration, an indicator of proton leak through the inner mitochondrial membrane, remained unaltered in digitoninpermeabilized and intact OPA1 siRNA cells ( Figure 4A ). Thus, OPA1 loss does not induce proton leak and mitochondrial uncoupling, but rather causes partial respiratory inhibition. The maximal rate of respiration may be limited by the transport of substrates and/or activity of the tricarboxylic acid cycle, in addition to the activity of the electron transport chain. To directly test Complex I activity coupled with the activity of downstream complexes, we measured rotenone-sensitive NADH-dependent respiration in alamethicin-permeabilized mitochondria. Figure 4B illustrates that the activity of electron transport chain (Complexes I-III-IV) was reduced by 39 ± 4% (n ¼ 4) in OPA1 siRNA cells. Consistent with the reduced respiratory capacity, OPA1 siRNA cells displayed lower ATP levels ( Figure 4C ).
Next, we determined the mitochondrial DNA copy number by quantitative PCR. The mitochondrial DNA (mtDNA) to nuclear DNA (nDNA) ratio was significantly decreased in OPA1 siRNA cells ( Figure 4D ). Thus, mitochondrial crista depletion and the mtDNA copy number decrease may be the causes of partial respiratory inhibition resulting from OPA1 loss.
To dissect further the downstream mechanism of mitochondrial dysfunction in OPA1 siRNA cells, we assessed mitochondrial Ca 2 þ retention capacity using digitonin-permeabilized cells. Extramitochondrial (Figure 4Ea ), and mitochondrial swelling (Figure 4Ec ), all indications of the mitochondrial permeability transition (MPT). Although Ca 2 þ -induced MPT occurred in both control and OPA1 siRNA cells, the threshold concentration of Ca 2 þ needed to trigger mitochondrial Ca 2 þ release was significantly lower in OPA1 siRNA cells ( Figure 4E ). An B25% decrease in Ca 2 þ retention capacity was observed ( Figure 4F ).
OPA1 loss alters histamine-induced Ca 2 þ transients in intact HeLa cells. Because mitochondrial Ca 2 þ retention capacity was reduced in digitonin-permeabilized OPA1 siRNA cells, we tested Ca 2 þ homeostasis in situ using live OPA1 loss leads to augmented reduction of the NAD(H) pool. Ca 2 þ activates NADH-producing dehydrogenases in the mitochondrial matrix, thereby increasing the NADH/ NAD þ ratio and rate of ATP synthesis. 24 NADH and NADPH exhibit indistinguishable autofluorescence, but under our experimental conditions, changes in NAD(P)H autofluorescence intensity are expected to reflect changes in the reduction state of the mitochondrial NAD(H) pool. This is because the pool size of NADP(H) is a fraction of the NAD(H) pool size, and is almost completely reduced under physiological conditions. To evaluate the Ca 2 þ -dependent bioenergetic status in situ, we measured the NAD(P)H autofluorescence in OPA1 siRNA cells. . In all, 52 crista junctions were measured for control (gray bar) and 47 crista junctions for OPA1 siRNA (black bar) mitochondria. For 11 control mitochondria (gray bar) and 26 OPA1 siRNA mitochondria (black bar), the number of crista junctions per mitochondrion was measured and then normalized to each inner boundary membrane surface area (measured from the segmented volume) to determine the density of junctions (b). The crista junction density for the OPA1 siRNA mitochondria was less than half for the control mitochondria; Po0.001
shown in Figure 5 , the relative peak amplitude triggered by the first application of histamine was diminished in OPA1 siRNA compared with control cells ( Figure 6B ). The decay time of NAD(P)H signals was shorter ( Figure 6C ) in OPA1 siRNA cells than in controls, which is consistent with the lower Ca 2 þ uptake capacity (Figures 5Aa and b) . To measure the NADH/NAD þ ratio after a series of histamine stimuli, autofluorescence was calibrated by first oxidizing mitochondrial NADH to NAD þ by uncoupling respiration using FCCP. Following FCCP treatment, Complex I was inhibited by rotenone and the substrate b-hydroxy-butyrate was added allowing maximal reduction of NAD þ to NADH ( Figure 6A ). In control cells, the reduction level of NAD(H) pool returned to baseline following the histamine series Figure 6D ). In contrast, OPA1 siRNA cells exhibited a higher NADH/NAD þ ratio ( Figure 6D ). An accumulation of NADH after a histamine-evoked [Ca 2 þ ] rise in OPA1 siRNA cells is consistent with a defective respiratory capacity, and this outweighs the diminished NADH production caused by decreased Ca 2 þ uptake.
OPA1 loss in RGCs has no impact on mitochondrial morphology, but triggers glutamate-induced DCD. To test the effects of OPA1 loss on Ca 2 þ homeostasis in a pathophysiological setting relevant to optic neuropathies, we purified RGCs by immunopanning. 36 Because RGC transfection efficiency was low, we labeled the siRNA with fluorescein (FAM) and determined the [Ca 2 þ ] c only of FAM-positive RGCs. Scrambled and OPA1 siRNA-transfected cells were stained similarly with MitoTracker Red (Figure 7 and Supplementary Figure 3 ) that indicated no substantial mitochondrial depolarization (as was also observed in HeLa cells; Figures 1A and 4E) . In contrast to HeLa cells, scrambled and OPA1 siRNA-transfected RGCs exhibited similar, short mitochondria (Figure 7a ). Neither mitochondrial length nor the longitudinal fraction of RGC processes occupied by mitochondria was significantly affected by OPA1 knockdown (Figure 7a and Supplementary Figure 3 (Figure 7c) . A significant proportion of control RGCs (6 out of 18) exhibited spontaneous reversibility of DCD, whereas in all OPA1 siRNA-transfected cells the secondary rise of [Ca 2 þ ] c was sustained and irreversible for the duration of the recording (Figure 7c) . Thus, OPA1 knockdown in RGCs conferred increased sensitivity to glutamate-mediated excitotoxicity, which may provide a mechanistic explanation for their degeneration in DOA.
Discussion
OPA1 is a key mediator of mitochondrial fusion, but it is currently unclear whether defects in OPA1-mediated fusion function are solely responsible for RGC degeneration in DOA. 8 Whereas HeLa cells exhibit a fused mitochondrial network that fragments into multiple round mitochondria after OPA1 loss, we report here that RGCs have much shorter mitochondria at baseline and undergo no significant change in size and shape upon OPA1 depletion. Previous studies reported mitochondrial fragmentation in OPA1 knockdown RGCs. 23, 37 However, morphological changes become apparent at longer post-transfection times (1 to 2 weeks), but not at 3 days after transfection. 37 Morphological changes coincided with induction of apoptosis and membrane depolarization. 23 All our experiments were performed no later than 3 days after transfection. Notably, despite a lack of mitochondrial shape transformation ( Figure 7 and Supplementary Figure 3) , we observed a significant change in Ca 2 þ handling. Thus, we propose that in RGCs, impaired Ca 2 þ homeostasis and DCD represent an early consequence of OPA1 loss, whereas other defects associated with fusion deficiency are possibly secondary or delayed effects.
Bioenergetic defects. The trigger for RGC loss in DOA likely has several components, not least of which is a bioenergetic crisis, and may also involve altered mitochondrial network dynamics, defective mtDNA maintenance, and disrupted axonal transport. 8 We found partial inhibition of respiration and decreased enzyme activity of electron transport chain complexes, but Dc m remained sufficiently high to support energy-dependent Ca 2 þ uptake ( Figure 4 ). In contrast, loss of mitochondrial fusion resulted in almost complete inhibition of respiration in mouse embryonic fibroblasts, 33 highlighting the variability of findings using different cellular models.
Because respiration inhibition quantitatively correlates with crista surface area reduction (25%; Figure 2 ), the partial loss of cristae observed here may be responsible for the bioenergetic deficiency seen in OPA1 siRNA cells and the moderate ATP decrease observed. Respiratory inhibition is consistent with observed excessive reduction of pyridine nucleotides (Figure 6 ), and this effect outweighs the 38 lending further support for OPA1 influencing bioenergetics. Reduced enzymatic activity of the respiratory chain reported here is also consistent with recent finding of Complex IV deficiency in OPA1-null pancreatic b-cells. 39 However, in this model, cells lacking OPA1 maintained normal copy numbers of mtDNA, 39 whereas we observed mtDNA loss (Figure 4 ). Our data are in line with the observation that mtDNA content is lower in DOA patients. 31 Ultrastructure. Several studies have demonstrated that loss of OPA1 (or its yeast ortholog Mgm1) leads to aberrant mitochondrial ultrastructure. 17, [40] [41] [42] [43] [44] [45] We observed a number of structural abnormalities consisting of rounded mitochondria with smaller and fewer cristae (not unlike what Amutha et al. 40 reported for Mgm1 deletion mutants) and a small fraction with condensed matrix or having cristae oriented parallel to the long axis of the organelles. At variance from an earlier study 6 showing a wide range of abnormal membrane structures in OPA1 siRNA mitochondria, including curved or ring-shaped cristae, unusual cristae shapes were not observed in our model (Figure 2 ). The variability of reported ultrastructural changes might be due to the different time points of knockdown.
We found that partial cristae depletion is associated with reduction in the number of cristae junction. Crista junction geometry has been proposed to control molecular diffusion inside mitochondria 46, 47 as well as the release of cytochrome c in apoptosis. 18, 20 However, in contrast to observations in pancreatic b-cells of OPA1 KO mice, 39 we did not observed dilation of crista junctions. It should be remarked that the crista junction dilation found in the pancreatic b-cells of OPA1 KO mice could be due to the increased matrix condensation observed in the study. 39 Impaired mitochondrial Ca 2 þ handling. The clinical manifestation of OPA1 mutations is often highly variable between siblings. 48 Experimental knockdown of OPA1 performed by different tools and laboratories resulted in highly variable phenotypes (see above). Ca 2 þ handling is not an exception from this. Here we report diminished agonist-evoked mitochondrial Ca 2 þ signaling consistent with attenuation of activation of matrix dehydrogenases in OPA1 knockdown cells. In contrast, Fulop et al. 22 reported increased histamineevoked mitochondrial Ca 2 þ transients in OPA1 knockdown cells, despite reduced Dc m , and a hastened kinetics of Ca 2 þ uptake in the absence of Dc m . We believe that this discrepancy can be explained by mitochondrial swelling, as they reported a high level of circularity of OPA1 knockdown mitochondria, an indicator of swelling. Mitochondrial Ca 2 þ -fluxes may be controlled by crista junction geometry. 46, 47 Dilation of crista junctions may occur by mechanical forces during overt matrix condensation, 39 or mitochondrial swelling. When mitochondria swell, crista unfolding might lead to breakdown of the diffusion barrier and increased mitochondrial Ca 2 þ uptake. In our study, OPA1 knockdown in HeLa cells did not lead to swelling and we observed only small number of condensed mitochondria (Figure 3) . The impact of crista and matrix remodeling on mitochondrial Ca 2 þ transport warrants further investigation. Dayanithi et al. 23 reported CCCP-triggered increase in intracellular Ca 2 þ levels after high [K þ ] stimulation in OPA1 RNAi RGCs. However, in this study extracellular Ca 2 þ was not removed from the medium, and therefore it is likely that the observed elevation of [Ca 2 þ ] c reflects Ca 2 þ entry from the extracellular space through voltage-dependent channels upon deenergization by CCCP rather than mitochondrial Ca 2 þ release. Our data in permeabilized cells clearly demonstrate that OPA1 knockdown reduces mitochondrial Ca 2 þ retention capacity ( Figure 4E ) and are consistent with impaired Ca 2 þ buffering capacity observed in situ ( Figure 5 ). Interestingly, a similar reduction in Ca 2 þ retention capacity was observed in dynamin-related protein 1 (Drp1)-and Fis1-expressing cells. 49 In contrast to the active, electrophoretic Ca 2 þ uptake addressed in our experiments, OPA1 knockdown resulted in increased rates of passive Ca 2 þ entry into mitochondria after depolarizing and swelling mitochondria in permeabilized HeLa cells.
22
Impaired Ca 2 þ homeostasis and neurodegeneration. Excessive glutamate exposure evokes irreversible, high elevation of [Ca 2 þ ] c and the inability of neurons to return to normal Ca 2 þ homeostasis, ultimately resulting in their demise. 25, 50 We report here that glutamate exposure results in irreversible DCD in OPA1 siRNA RGCs, whereas a significant fraction of control RGCs recovered and exhibited reversible DCD, indicating some level of resistance to excitotoxic damage, as was observed earlier. 31 Interestingly, the NMDA receptor inhibitor memantine is able to protect RGCs in glaucomatous retinas and prevent release of OPA1 from mitochondria. 51 Using cerebellar granule neurons, Jahani-Asl et al. 52 showed that NMDA receptor overactivation triggers downstream Calpain activation, loss of OPA1 oligomers, deformation of crista junctions, and disruption of the respiratory chain complexes. Importantly, calpain activation is secondary to DCD. 30 Therefore, loss of OPA1 might exert its deleterious effects under excitotoxic conditions by downstream activation of the cell death mediator Ca 2 þ -dependent calpain.
DCD is controlled by two factors: initial mitochondrial Ca 2 þ load upon glutamate exposure 53 and bioenergetic capacity of mitochondria. 54 Based on our data, mitochondrial Ca 2 þ load is likely to be reduced in OPA1-deficient RGCs, and therefore the aggravation of DCD that was observed is possibly due to the decreased respiratory capacity. Along this line, DOA patients with higher respiratory complex activities have been reported to maintain visual acuity for a longer period of time, 48 again suggesting that the bioenergetic compromise may be at the root of RGC damage. Because RGC mitochondria do not show any abnormalities in protein expression, the focus should turn to RGC idiosyncrasies in terms of mitochondrial energy metabolism and environmental stress factors. 3 Our work suggests that inhibitors of excitotoxic injuries should be considered for therapeutic intervention in DOA.
Materials and Methods
Unless indicated otherwise, chemicals were of analytical or molecular biology grade and purchased from Sigma-Aldrich (St. Louis, MO, USA) or Thermo-Fisher Scientific (Waltham, MA, USA).
Cell culture. HeLa cells were purchased from American Tissue Culture Company (ATCC; Manassas, VA, USA) and grown in Dulbecco's modified Eagle's medium (DMEM; HyClone-Thermo-Fisher, Logan, UT, USA) containing 4.5 g/l glucose, 2 mM L-glutamine, 10% fetal bovine serum (FBS) (Tissue Culture Biologicals, Los Alamitos, CA, USA), containing 100 units/ml penicillin and 1000 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). RGCs were isolated from postnatal rats by immunopanning 36 and used at 7 days in vitro.
RNA interference. Scrambled I duplex (control) and OPA1 siRNA, the latter corresponding to nucleotides 1810-1833 of the OPA1 open reading frame (GenBank accession number AB011139) were from Dharmacon (Lafayette, CO, USA). SiRNA (100-200 nM) was transfected into HeLa or RGCs with Oligofectamine (Invitrogen). To verify siRNA transfer in RGCs, siRNA was labeled with FAM (Ambion, Austin, TX, USA). Experiments were performed on day 3 after transfection.
Subcellular fractionation and immunoblotting. Subcellular fractionation and immunoblotting were done as described previously. 55 The primary antibody for cytochrome c was mouse monoclonal anti-cytochrome c (1 : 1000; clone 7H8.2.84; BD Biosciences Pharmingen, Franklin Lakes, NJ, USA). The OPA1 antibody (1 : 1000) was a gift from Dr. Kubo. Blots were probed with secondary HRP-conjugated anti-mouse antibody (1 : 2000; Amersham Biosciences, Piscataway, NJ, USA) for 2 h and immunocomplexes were visualized using a chemiluminescence detection kit (ECL) (Amersham Biosciences).
Fluorescence microscopy. HeLa cells were grown on 35 mm MatTek glass bottom dishes and mitochondria were labeled with 100 nM MitoTracker Red CMXRos (Molecular Probes, Eugene, OR, USA) for 20 min in culture medium. Cells were fixed with 0.5% glutaraldehyde (Ted Pella, Redding, CA, USA) in icecold PBS (HyClone-Thermo-Fisher) for 30 min and autofluorescence was quenched by 1% sodium borohydrite (Sigma-Aldrich) for 30 min at room temperature. Nuclei were stained with Hoechst 33342 (0.1 mg/ml; Molecular Probes). The 3D images were acquired using a Zeiss Axiovert 100M fluorescence microscope (Oberkochen, Germany) equipped with a Sensicam CCD camera controlled by Slidebook software (Intelligent Imaging Innovation, Denver, CO, USA). The z-series were deconvolved using the Slidebook constrained iterative algorithm and volumes were surfacerendered using Volocity 2 (Improvision, Coventry, UK).
Electron microscopy. HeLa cells were fixed as described. 42 Roughly 80-nm thick sections were cut with a Reichert (Cambridge, England, UK) ultramicrotome and poststained 10 min in uranyl acetate and 2 min in Sato lead. Sections were examined using a JEOL (Peabody, MA, USA) 1200FX electron microscope operated at 80 kV. Images were recorded on film at 6000 magnification. The negatives were digitized at 1200 d.p.i. using a Nikon (Melville, NY, USA) CoolScan system, giving an image size of 2689 Â 4006 pixel array and a pixel resolution of 4.2 nm.
EM tomography. Sections from in situ embedded monolayers of scrambled or OPA1 siRNA-transfected HeLa cells were cut at a thickness of 400-500 nm. EM tomography was performed as described. 56 Measurements of structural features were made within segmented volumes by the programs Synuarea and Synuvolume (National Center for Microscopy and Imaging Research, San Diego, CA, USA). Numbers of mitochondria were counted in the volume and normalized by dividing by the cytoplasmic volume reconstructed.
Q-PCR. To quantify mtDNA, real-time PCR was performed as described 57 using a Mx3000P real time PCR system (Stratagene, La Jolla, CA, USA) and SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Total cellular DNA was purified with a PUREGENE Cell & Tissue kit (Gentra Systems, Minneapolis, MN, USA) 3 days after siRNA transfection. Serially diluted total cellular DNA from untransfected cells was used as a template for two standard DNA curves, one for amplification with nDNA primers and the second one with mtDNA primers. The relative quantity of amplified DNA was determined from respective standard curves for each sample, starting with 10 ng for nDNA and 0.1 ng for mtDNA and the mtDNA/nDNA ratio was calculated.
ATP measurements and cell viability. HeLa cells were plated on black 96-well plates (Costar, Corning, Corning, NY, USA). ATP levels were determined using a CellTiter-Glo luminescence assay kit (Promega, Madison, WI, USA). Luminescence was measured in a PolarStar plate reader (BMG, Berlin, Germany). Each data set was collected from replicate wells (n ¼ 6).
For cell viability measurements, cells were loaded with 2 mM Calcein-AM (Molecular Probes) in PBS. Generation of fluorescent Calcein was followed for 20 min at 490 nm excitation and 540 nm emission using a PolarStar plate reader. Cell viability of scrambled or OPA1 siRNA-transfected cells was expressed as the percentage of the rate of Calcein-AM hydrolysis measured from untransfected control cells (defined as 100%). Each data set was collected from replicate wells (n ¼ 6-8). Caspase activity was measured using the fluorogenic substrate z-DEVD-AMC (Molecular Probes). Apoptotic cell death was measured by Annexin-V-FITC staining as described previously. 42 Cytochrome c immunocytochemistry and confocal microscopy. HeLa cells were grown on MatTek dishes and fixed with 3.7% formaldehyde in KCl-based PIPES-KOH, pH 7.2, buffer containing 5% sucrose, for 15 min at 371C and permeabilized with 1% Triton in PBS for 20 min at 371C. Non-specific binding was blocked in 2% BSA, 0.05% Tween-20, and 0.1% NaN 3 for 40 min at 371C. Samples were incubated with anti-cytochrome c antibodies in blocking solution (1 : 200, subclone 6H2B4, BD PharMingen, San Diego, CA, USA) overnight at 41C. Samples were incubated with secondary Alexa488-conjugated antibodies (1 : 200, Molecular Probes) for 2 h at room temperature. Confocal imaging was carried out using an Olympus (Tokyo, Japan) Fluoview-1000 laser scanning confocal microscope. Image stacks of 800 Â 800 pixels, 20 planes (0.09 Â 0.09 Â 0.5 mm 3 voxel size) were recorded and projected over maximum intensity. For excitation of Hoechst 33342, Alexa-488, and MitoTracker Red, the 405, 488, and 543 nm laser lines of a diode, an Ar-ion, and a He-Ne laser, respectively, were used. Emission was detected through a DM405/488/543 dichromic mirror and the spectral detector of the microscope at 420-480, 500-530, and 4560 nm, respectively.
Respiration measurements. Oxygen consumption was measured using a Clark-type electrode (Oxygraph, Hansatech Instruments, King's Lynn, UK). HeLa cells were trypsinized, centrifuged at 500 Â g, and resuspended in the culture medium. For measurements in intact cells, 8 Â 10 6 cells were pelleted at 200 Â g, 2 min and resuspended in 1 ml DMEM. After recording basal respiration for 2 to 3 min, oligomycin (1.25 mg/ml) was added followed by sequential additions of FCCP (100 nM). Respiration rates were normalized for equal numbers of live cells, evaluated by Trypan Blue exclusion.
For measurements in permeabilized cells, 8 Â 10 6 cells were resuspended in 1 ml buffer containing 250 mM sucrose, 10 mM HEPES/KOH, pH 7.4, 2 mM KH 2 PO 4 , centrifuged at 200 Â g, 2 min, and resuspended in 1 ml of respiration buffer containing 125 mM KCl, 20 mM HEPES/KOH, pH 7.4, 2 mM KH 2 PO 4 , and 1 mM MgCl 2 . Then, 5 mM glutamate and 5 mM malate were added as respiratory substrates. The plasma membrane was permeabilized by addition of titrated amounts of digitonin (0.012%). ADP (200 mM), oligomycin (1.25 mg/ml), and FCCP (200 nM) were added, as noted.
Measurements of mitochondrial Ca
2 þ retention capacity, Dw m , and mitochondrial swelling. A custom-made chamber was used to simultaneously measure [Ca 2 þ ], Dc m , and optical density at 660 nm as described previously. 58 To measure the Ca 2 þ retention capacity, 8 Â 10 6 siRNA-transfected cells were permeabilized with digitonin (0.012%) in 1 ml of sucrose-based buffer and pelleted at 200 Â g. Cells were resuspended in the respiration buffer plus 2 mM tetraphenylphosphonium (TPP þ ) and without MgCl 2 and pulsed with successive Ca 2 þ (50 mM) additions. Ca 2 þ retention capacity was defined as the amount of Ca 2 þ required to induce Dc m loss and Ca 2 þ release.
Measurements of Complex I-III-IV enzyme activity. An assay of mitochondrial enzyme activity using a pore-forming peptide, alamethicin, has been described. 59 Briefly, 8 Â 10 6 cells were permeabilized with 0.012% digitonin and mitochondria were permeabilized with 30 mg/ml alamethicin in respiration buffer (see above) containing 2 mM cytochrome c. Oxygen consumption induced by 2 mM NADH was measured for 2 to 3 min followed by rotenone (2 mM) addition. The rate of rotenone-insensitive respiration was subtracted from the total rate of NADH-dependent respiration. For selective assessment of [Ca 2 þ ] m , high-resolution images were taken (512 Â 512 16-bit 0.26 mm/pixel; at 5 s intervals) and fluorescence originating from mitochondria was separated by high-pass filtering of fluorescent images, whereas [Ca 2 þ ] c was determined over the nucleus 35 using Metafluor Analyst (Molecular Devices).
For RGCs, MitoTracker Red and FAM fluorescence was measured once at the start of the experiment (512 Â 512 16-bit 0.8 mm/pixel). Length and presence of mitochondria in processes of RGCs were determined by high-pass filtering and segmentation of images using locally adaptive techniques in Image Analyst MKII. Finally, the skeletal length of mitochondria and processes were calculated for FAMpositive cells. Mitochondrial length is given as mean skeletal length. Mitochondrial presence is defined as total mitochondrial length per total neurite length (see Supplementary Figure 3B ). During time-lapse experiments, Fura-FF signals were recorded at 2 Â 2 binning (256 Â 256; 16-bit; 1.6 mm/pixel; 5 s/ratio frame). Fura-FF (K d ¼ 2.9 mM) ratios were calibrated to [Ca 2 þ ] by exposing each sample to zero and high (10 mM) [Ca 2 þ ] at the end of the experiment with a procedure previously described. 30 The Ca 2 þ calibration and analysis of Ca 2 þ extrusion rates were performed in Mathematica 5.2 (Wolfram Research, Oxfordshire, England, UK).
NADH autofluorescence in HeLa cells was measured using 340/10 nm excitation and 465/30 nm emission filters. Images were taken at 256 Â 256 pixels; 16-bit; 0.8 mm/pixel, at 10 s intervals. Decay slope and half-life of fluorescence transients in histamine-stimulated cells were determined by standard functions in Mathematica 5.2. The percentage of NAD(H) reduction was expressed from the NAD(P)H autofluorescence intensity before application of FCCP scaled between the intensities measured in the presence of FCCP (0%) and rotenone (100%).
